
    
      A Phase I, Single Centre, Double-blind, Randomised, Placebo-controlled, Parallel-group Study
      to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of inhaled AZD8683
      after Single Ascending Doses administered via Turbuhaler in Healthy Subjects
    
  